These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 16190367)

  • 1. [Role of endogenous tPA in stroke].
    Umemura K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2005 Aug; 25(4):183-8. PubMed ID: 16190367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-type plasminogen activator has paradoxical roles in focal cerebral ischemic injury by thrombotic middle cerebral artery occlusion with mild or severe photochemical damage in mice.
    Nagai N; Zhao BQ; Suzuki Y; Ihara H; Urano T; Umemura K
    J Cereb Blood Flow Metab; 2002 Jun; 22(6):648-51. PubMed ID: 12045662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential role of endogenous tissue plasminogen activator through matrix metalloproteinase 9 induction and expression on heparin-produced cerebral hemorrhage after cerebral ischemia in mice.
    Zhao BQ; Ikeda Y; Ihara H; Urano T; Fan W; Mikawa S; Suzuki Y; Kondo K; Sato K; Nagai N; Umemura K
    Blood; 2004 Apr; 103(7):2610-6. PubMed ID: 14630814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroserpin, a neuroprotective factor in focal ischemic stroke.
    Cinelli P; Madani R; Tsuzuki N; Vallet P; Arras M; Zhao CN; Osterwalder T; Rülicke T; Sonderegger P
    Mol Cell Neurosci; 2001 Nov; 18(5):443-57. PubMed ID: 11922137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-type plasminogen activator is involved in the process of neuronal death induced by oxygen-glucose deprivation in culture.
    Nagai N; Yamamoto S; Tsuboi T; Ihara H; Urano T; Takada Y; Terakawa S; Takada A
    J Cereb Blood Flow Metab; 2001 Jun; 21(6):631-4. PubMed ID: 11488532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adiponectin prevents cerebral ischemic injury through endothelial nitric oxide synthase dependent mechanisms.
    Nishimura M; Izumiya Y; Higuchi A; Shibata R; Qiu J; Kudo C; Shin HK; Moskowitz MA; Ouchi N
    Circulation; 2008 Jan; 117(2):216-23. PubMed ID: 18158361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microglial low-density lipoprotein receptor-related protein 1 mediates the effect of tissue-type plasminogen activator on matrix metalloproteinase-9 activity in the ischemic brain.
    Zhang C; An J; Haile WB; Echeverry R; Strickland DK; Yepes M
    J Cereb Blood Flow Metab; 2009 Dec; 29(12):1946-54. PubMed ID: 19672275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of endogenous versus exogenous tPA on edema formation in murine ICH.
    Thiex R; Mayfrank L; Rohde V; Gilsbach JM; Tsirka SA
    Exp Neurol; 2004 Sep; 189(1):25-32. PubMed ID: 15296833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral venous congestion as indication for thrombolytic treatment.
    Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
    Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke.
    Ning M; Furie KL; Koroshetz WJ; Lee H; Barron M; Lederer M; Wang X; Zhu M; Sorensen AG; Lo EH; Kelly PJ
    Neurology; 2006 May; 66(10):1550-5. PubMed ID: 16717217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue plasminogen activator extravasated through the cerebral vessels: evaluation using a rat thromboembolic stroke model.
    Harada T; Kano T; Katayama Y; Matsuzaki T; Tejima E; Koshinaga M
    Thromb Haemost; 2005 Oct; 94(4):791-6. PubMed ID: 16270632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue-type plasminogen activator modulates inflammatory responses and renal function in ischemia reperfusion injury.
    Roelofs JJ; Rouschop KM; Leemans JC; Claessen N; de Boer AM; Frederiks WM; Lijnen HR; Weening JJ; Florquin S
    J Am Soc Nephrol; 2006 Jan; 17(1):131-40. PubMed ID: 16291841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the duration of middle cerebral artery occlusion on the risk of hemorrhagic transformation after tissue plasminogen activator injection in rats.
    Copin JC; Gasche Y
    Brain Res; 2008 Dec; 1243():161-6. PubMed ID: 18835259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin attenuates the postischemic increase in blood-brain barrier permeability and decreases hemorrhagic transformation of tissue-plasminogen activator therapy following ischemic stroke in mice.
    Chen TY; Lee MY; Chen HY; Kuo YL; Lin SC; Wu TS; Lee EJ
    J Pineal Res; 2006 Apr; 40(3):242-50. PubMed ID: 16499561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of NOX1 for angiotensin II-induced cerebrovascular superoxide production and cortical infarct volume following ischemic stroke.
    Jackman KA; Miller AA; Drummond GR; Sobey CG
    Brain Res; 2009 Aug; 1286():215-20. PubMed ID: 19559686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma kallikrein mediates brain hemorrhage and edema caused by tissue plasminogen activator therapy in mice after stroke.
    Simão F; Ustunkaya T; Clermont AC; Feener EP
    Blood; 2017 Apr; 129(16):2280-2290. PubMed ID: 28130211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of tissue plasminogen activator in the sensitization of methamphetamine-induced dopamine release in the nucleus accumbens.
    Fukakusa A; Nagai T; Mizoguchi H; Otsuka N; Kimura H; Kamei H; Kim HC; Nabeshima T; Takuma K; Yamada K
    J Neurochem; 2008 Apr; 105(2):436-44. PubMed ID: 18036193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective role of tuftsin fragment 1-3 in an animal model of intracerebral hemorrhage.
    Wang J; Rogove AD; Tsirka AE; Tsirka SE
    Ann Neurol; 2003 Nov; 54(5):655-64. PubMed ID: 14595655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiactin-targeted immunoliposomes ameliorate tissue plasminogen activator-induced hemorrhage after focal embolic stroke.
    Asahi M; Rammohan R; Sumii T; Wang X; Pauw RJ; Weissig V; Torchilin VP; Lo EH
    J Cereb Blood Flow Metab; 2003 Aug; 23(8):895-9. PubMed ID: 12902833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin decreases matrix metalloproteinase-9 activation and expression and attenuates reperfusion-induced hemorrhage following transient focal cerebral ischemia in rats.
    Hung YC; Chen TY; Lee EJ; Chen WL; Huang SY; Lee WT; Lee MY; Chen HY; Wu TS
    J Pineal Res; 2008 Nov; 45(4):459-67. PubMed ID: 18624955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.